Background Chemotherapy (CT) combined with radiotherapy is the standard treatment of
'limited-stage'small-cell lung cancer. However, controversy persists over the optimal timing …

Purpose To replicate an earlier National Cancer Institute of Canada (NCIC) trial that
examined the effect on survival of the timing of thoracic radiotherapy (TRT) in patients with …

Purpose We employed meta-analytic techniques to evaluate early (E) versus late (L) timing
of thoracic radiation therapy (RT) in limited-stage small-cell lung cancer (LS-SCLC). In …

Background: We undertook a systematic review and literature-based meta-analysis to
determine whether the timing of chest radiotherapy may influence the survival of patients …

BACKGROUND: We undertook a systematic review and literature-based meta-analysis to
determine whether the timing of chest radiotherapy may influence the survival of patients …

Purpose To identify time factors for combined chemotherapy and radiotherapy predictive for
long-term survival of patients with limited-disease small-cell lung cancer (LD-SCLC) …

© Translational lung cancer research. All rights reserved. Transl Lung Cancer Res 2015; 4
(3): 292-294 www. tlcr. org chemotherapy, whereas other studies in the literature measured …

Background This is an update of the original review published in Issue 1, 2005. It is standard
clinical practice to combine chemotherapy and chest radiotherapy in treating patients with …

Although meta-analysis of randomized trials comparing chemotherapy alone versus
chemotherapy plus thoracic irradiation demonstrated that thoracic radiotherapy reduced …

Background We compared late thoracic radiotherapy (TRT) with early TRT in the treatment
of limited-disease small-cell lung cancer (LD-SCLC). Patients and methods Patients with LD …